Stock screener

CRNX

Conviction 37HealthcareScan · Thu, Jun 25, 2026
CRNX$35.01-3.25%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
Vol MA14 1.68M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Crinetics Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.crinetics.com ↗
Price35.01
Change-3.25%
Gap-0.11%
Rel volume8.59×
Avg volume1.51M
Avg $ vol52.69M
SMA 2034.72
SMA 5036.93
SMA 20041.75
Price vs 50-5.20%
Price vs 200-16.15%
MA stackbearish
50/200 cross—
Supertrenddown · 38.00
RSI (14)47
MACD hist0.28
MACD crossbull · 8d
Stoch %K / %D47 / 64
ADX (14)13
+DI / −DI23 / 20
RSI divergence—
MACD divergenceBullish
ATR %+4.83%
ADR %4.44%
52w high56.43
52w low26.85
From 52w high-37.97%
Above 52w low+30.37%
New 52w highNo
SqueezeOff
Bollinger width12.27%
%B0.57
Donchian pos50.42%
Donchian high37.67
Donchian low32.30
AVWAP (52w high)41.16
vs AVWAP high-14.96%
AVWAP (52w low)40.90
vs AVWAP low-14.42%
OBV trendDown
Chaikin MF (20)-0.33
Today vs 20d8.59×
Avg vol (14d)1.68M
Avg vol (20d)1.51M
Avg $ vol (20d)52.69M
Market cap3.69B
RS 3m (vs SPY)-6.99%
RS 6m (vs SPY)-32.38%
RS line new highNo
Trend template3/8
Technical rank21.5
1 week-2.08%
1 month-4.83%
3 months-3.67%
6 months-28.91%
1 year+13.14%
YTD-25.09%
P/E-7.93
P/B2.88
P/S479.59
P/FCF-9.62
EPS-4.95
Div yield—
ROE-36.33%
ROA-33.21%
Debt/Eq—
Current18.60
EV/EBITDA-6.97
Gross margin—
Net margin—
Rev growth640.71%
EPS growth-55.93%
Price target88.90
Target upside153.96%
Analyst ratingBuy
Institutional125.24%
Ent. value3.58B
Revenue10.73M
Net income-127.84M
Gross profit—
Free cash flow-383.68M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out105.44M
Employees594
ListedWed, Jul 18, 2018
Free float100.71M
Float %95.5%
Short interest12.64M
Days to cover13.8d
Short volume52.2%
Squeeze score73 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$1.23 · 6 est
Last EPS vs est−$1.23 vs −$1.22
Last surprise-0.8% miss
Setup gradeD
Conviction37 / 100
Pattern quality—
Tech rank21.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance41.06
Support32.50
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRNX · 5 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-03
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-17
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-03-19
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-01-29
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · NJ · traded 2024-09-25
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in CRNX · 10 buys

InsiderSideShares
Fust Matthew K
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
Deardorf Caren
Director · Common Stock · 2026-06-18
Grant5.92K
Deardorf Caren
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
Okey Stephanie
Director · Common Stock · 2026-06-18
Grant5.92K
Okey Stephanie
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
WIERENGA WENDELL
Director · Common Stock · 2026-06-18
Grant5.92K
Bedrosian Camille L
Director · Common Stock · 2026-06-18
Grant5.92K
Bedrosian Camille L
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
WIERENGA WENDELL
Director · Stock Option (Right to Buy) · 2026-06-18
Grant9.73K
Vivaldi Coelho Rogerio
Director · Common Stock · 2026-06-18
Grant5.92K

SEC filings

EDGAR filings in CRNX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.